DNAJC2 and breast cancer: Since ZRF1 knockdown MCF7 cells exhibited such a robust phenotype after TAM treatment, we investigated their response towards pure anti-estrogen ICI 182,780 (ICI), which is used for the treatment of Tamoxifen resistant breast cancer tumors in the clinic.